CARGO Therapeutics, Inc. Common Stock
CARGO Therapeutics, Inc. Common Stock（CRGX）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
crgx · 股价预测 · 7 位分析师（近3月）· FMP · 更新于 2025年8月19日
分析师评级与共识
基于过去 3 个月内 7 位华尔街分析师
Hold
7 位分析师
共识
评级分布
12 个月目标价
High
$34.00
Consensus
$23.00
+414.5% upside
Low
$7.00
Median: $28 · Last Close: $4.47
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$23.00
414.5% upside
High Target
$34
660.6%
Low Target
$7
56.6%
Current Price
$4.47
as of today
Based on analyst price targets, the CRGX stock price prediction for the next 12 months ranges from $7 to $34. The consensus CRGX price forecast of $23.00 implies 414.5% upside from the current price of $4.47.
短期股价预测
Ranging算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $4.47 | ↓ 0.00% |
1-day model range: $4.47–$4.47. Peak: $4.47 (-0.00%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · CRGX · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-07-08 | Jefferies | Maintains | Hold→Hold |
| 2025-01-30 | JP Morgan | Downgrade ↓ | Overweight→Underweight |
| 2025-01-30 | Jefferies | Downgrade ↓ | Buy→Hold |
| 2025-01-30 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2025-01-30 | Truist Securities | Downgrade ↓ | Buy→Hold |
| 2025-01-30 | Chardan Capital | Downgrade ↓ | Buy→Neutral |
| 2025-01-30 | William Blair | Downgrade ↓ | Outperform→Market Perform |
| 2025-01-30 | Piper Sandler | Downgrade ↓ | Overweight→Neutral |
| 2024-11-15 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-11-13 | Chardan Capital | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on CARGO Therapeutics, Inc. Common Stock (CRGX) stock. Of the recent 14 rating actions, 0 were upgrades and 7 were downgrades. 7 analysts currently cover CRGX.
分析师推荐趋势
CRGX analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$1M
↓ 99.7% YoY
Revenue Next Year
$2M
↑ 229.6% YoY
EPS This Year
$-3.38
EPS Next Year
$-1.52
↓ 55.1% YoY
EPS ForecastReported vs Estimated
Analysts forecast CRGX EPS of $-3.38 for the current fiscal year, based on estimates from 3 analysts. The CRGX revenue forecast is $1M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
CRGX 股价预测由两类独立数据源支撑：来自 7 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。CRGX 的共识目标价为 $23.00（+414.5% 上行空间），分析师共识为 Hold。
CRGX 的短期预测（明日）为 $4.47（-0.00%）。
CARGO Therapeutics, Inc. Common Stock 在 NASDAQ 上市，代码 CRGX。CRGX 在 2027 年的整体展望偏中性/分化，在覆盖分析师中约 0% 对应 Hold 共识。
常见问题
CRGX 预测 · 8 个问题根据 7 位华尔街分析师，CRGX 的 12 个月平均目标价为 $23.00，最高 $34.00、最低 $7.00。若有图表，中位目标价可在上方查看。相对当前价 $4.47，隐含约 +414.5% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.